Home Antibody All anti-CXCR4 antibodies
Also for CXCR4 (NM_001008540)
|CXCR4 antibody was raised against a peptide corresponding to amino acids near the amino terminus of human CXCR4.|
||0.5~1.0 mg/ml (Lot Dependent)
||ELISA, WB: 1 - 2 ug/ml, ICC: 10 ug/ml, IP: 10 ug/ml, IF: 20 ug/ml, FC: 20 ug/ml
|PBS containing 0.02% sodium azide.|
|Antibody is DEAE purified (Protein A or G Sepharose)
|Homo sapiens chemokine (C-X-C motif) receptor 4 (CXCR4), transcript variant 1|
|CD184; D2S201E; FB22; HM89; HSY3RR; LAP3; LCR1; LESTR; NPY3R; NPYR; NPYRL; NPYY3R; WHIM|
|Human immunodeficiency virus (HIV) and related viruses require coreceptors, in addition to CD4, to infect target cells. Some G protein-coupled receptors including CCR5, CXCR4, CCR3, CCR2b and CCR8 in the chemokine receptor family, and four new human molecules GPR15, STRL33, GPR1 and V28 were recently identified as HIV coreceptors. Among them, CXCR4 (fusin, LESTR or HUMSTR) is a principal coreceptor for T-cell tropic strains of HIV-1 fusion and entry of human white blood cells. CXCR4 is also required for the infection by dual-tropic strains of HIV-1 and mediates CD-4 independent infection by HIV-2. The a-chemokine SDF-1 is the ligand for CXCR4 and prevents infection by T-tropic HIV-1. CXCR4 associates with the surface CD4-gp120 complex before HIV enters target cells. CXCR4 messenger RNA levels correlated with HIV-1 permissiveness in diverse human cell types. Antibodies to CXCR4 block HIV-1 and HIV-2 fusion and infection of human target cells. The amino-terminal domain and the second extracellular loop of CXCR4 serve as HIV binding sites.|
Cytokine-cytokine receptor interaction
Signaling by GPCR
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of CXCR4 in HeLa whole cell lysate with CXCR4 antibody at 0.5 ug/ml.
Immunohistochemistry of CXCR4 in HeLa cells with CXCR4 antibody at 2 ug/ml.